Picture of NANOSONICS logo

NAN — NANOSONICS News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Australia's Nanosonics gains; Morningstar says stock is undervalued

** Shares of Australia's Nanosonics  NAN.AX  rise as much as
1.4% to A$3
    ** Morningstar says the healthcare firm's stock is
undervalued; keeps A$4 fair value estimate and narrow moat
rating
    ** Brokerage also maintains its earnings outlook, saying
recent earnings headwinds will be largely temporary
    ** Morningstar's FY25 EBIT forecast of A$30 mln ($20.25 mln)
implies strong recovery on FY24 EBIT forecast of A$4 mln
    ** Avg rating of 11 analysts is equivalent of "hold" and
their median PT is about A$3 –LSEG data
    ** Stock has lost nearly 33% so far this year, after a 2.5%
gain last year
 
 ($1 = 1.4815 Australian dollars)

 (Reporting by Rishav Chatterjee in Bengaluru)
 ((Rishav.Chatterjee@thomsonreuters.com;))

Recent news on NANOSONICS

See all news